Tests lymph node surgery for certain lung spot on CT
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at whether removing lymph nodes in different ways improves outcomes for people with a specific kind of lung nodule seen on CT (a “ground-glass” spot with a mostly solid part). You may qualify if you are planning lung surgery and the CT measurements match the study’s exact thresholds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 75 years old
- A recent thin-slice lung CT (done within 1 month) shows a ground-glass nodule
- The nodule is under 3 cm at its largest point
- The solid part of the nodule is between 50% and 100%
- You are medically able to have a lobectomy (removing one lung lobe)
- You can understand the study and sign consent in writing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether different lymph node removal methods during lung surgery change outcomes for certain abnormal lung spots. It focuses on ground-glass nodules that stay the same after treatment-free observation and have a mostly solid portion on CT.
This Phase 2 trial studies whether a procedure called “ablation” is safe and effective for certain lung cancers that appear as ground-glass spots on CT scans and do not improve after 3 months. It may help people who cannot fully have surgery for their condition.
This study looks at whether people with a very early type of lung cancer can safely have curative surgery when their CT scan shows a ground-glass type spot with certain size and shape measurements. It aims to help doctors choose the right surgery approach based on the scan features and final pathology.
This trial compares removing fewer lymph nodes during surgery for early-stage non-small cell lung cancer. It is for people with a small tumor (2 cm or less) that has both solid and ground-glass parts.
This trial is testing a lung-sparing surgery called segmentectomy for people with a certain type of lung cancer nodule. It aims to see if this surgery is a good option for those with solid-dominant nodules that are 2 to 3 cm in size and have not spread to lymph nodes.
This trial tests how well a computer model predicts which lymph nodes need to be removed during lung cancer surgery. If you have early-stage lung cancer that can be removed, you may be eligible.
Hear when a new Progression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.